|Articles|August 27, 2019
Containing Cytotoxic Product during Transport
Author(s)Flow Sciences, Inc.
The purpose of this document is to serve as a case study where a containment device was designed to facilitate “interim containment”, or containment during the portion of a process where the product isn’t inside the enclosure.
Related Content
Trending on Pharmaceutical Technology
1
Technology Transfer: Success Drivers and Obstacles Explained
2
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
3
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5